- Product category
-
Human cells
- Organism
-
Homo sapiens, human
- Cell type
- epithelial cell
- Morphology
- epithelial
- Tissue
- Breast; Mammary gland
- Disease
-
Adenocarcinoma
- Applications
-
3D cell culture
- Product format
- Frozen
- Storage conditions
-
Vapor phase of liquid nitrogen
Documentation
ATCC determines the biosafety level of a material based on our risk assessment as guided by the current edition of Biosafety in Microbiological and Biomedical Laboratories (BMBL), U.S. Department of Health and Human Services. It is your responsibility to understand the hazards associated with the material per your organization’s policies and procedures as well as any other applicable regulations as enforced by your local or national agencies.
ATCC highly recommends that appropriate personal protective equipment is always used when handling vials. For cultures that require storage in liquid nitrogen, it is important to note that some vials may leak when submersed in liquid nitrogen and will slowly fill with liquid nitrogen. Upon thawing, the conversion of the liquid nitrogen back to its gas phase may result in the vial exploding or blowing off its cap with dangerous force creating flying debris. Unless necessary, ATCC recommends that these cultures be stored in the vapor phase of liquid nitrogen rather than submersed in liquid nitrogen.
Detailed product information
General
- Specific applications
-
These cells are suitable as a transfection host.
Characteristics
- Growth properties
- Adherent and/or suspension
- Age
- 69 years
- Ethnicity
- White
- Sex
- Female
- Karyotype
-
modal number = 82; range = 66 to 87.
The stemline chromosome numbers ranged from hypertriploidy to hypotetraploidy, with the 2S component occurring at 1%. There were 29 to 34 marker chromosomes per S metaphase; 24 to 28 markers occurred in at least 30% of cells, and generally one large submetacentric (M1) and 3 large subtelocentric (M2, M3, and M4) markers were recognizable in over 80% of metaphases. No DM were detected. Chromosome 20 was nullisomic and X was disomic. - Oncogene
- wnt7b
- Metastatic
- Pleural effusion
- Antigen expression
-
Blood Type O; Rh+
- Genes expressed
- insulin-like growth factor binding protein (IGFBP) BP-2; insulin-like growth factor binding protein (IGFBP) BP-4; insulin-like growth factor binding protein (IGFBP) BP-5
- Expression markers
- Estrogen receptor, expressed
- Isoenzymes
-
AK-1, 1ES-D, 1-2G6PD, BGLO-I, 1-2PGM1, 1-2PGM3, 1
- Comments
-
The MCF7 line retains several characteristics of differentiated mammary epithelium including ability to process estradiol via cytoplasmic estrogen receptors and the capability of forming domes. The cells express the WNT7B oncogene.RefHuguet EL, et al. Differential expression of human Wnt genes 2, 3, 4, and 7B in human breast cell lines and normal and disease states of human breast tissue. Cancer Res. 54: 2615-2621, 1994. PubMed: 8168088Growth of MCF7 cells is inhibited by tumor necrosis factor alpha (TNF alpha).Secretion of IGFBP's can be modulated by treatment with anti-estrogens.
Handling information
- Unpacking and storage instructions
-
- Check all containers for leakage or breakage.
- Remove the frozen cells from the dry ice packaging and immediately place the cells at a temperature below -130°C, preferably in liquid nitrogen vapor, until ready for use.
- Complete medium
-
The base medium for this cell line is ATCC-formulated Eagle's Minimum Essential Medium (ATCC 30-2003). To make the complete growth medium, add the following components to the base medium:
1.4 mL Gibco™ Insulin, human recombinant, zinc solution (4 mg/mL stock); Thermofisher catalog # 12585-014
fetal bovine serum to a final concentration of 10%.
- Temperature
-
37°C
- Atmosphere
-
95% Air, 5% CO2
- Handling procedure
-
To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.
- Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 minutes).
- Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.
- It is recommended that the cryoprotective agent be removed immediately. Transfer the vial contents to a centrifuge tube containing 9.0 mL complete culture medium and centrifuge the cell suspension at approximately 150-400 x g for 8-12 minutes (280xg for 10 min). Discard the supernatant and resuspend the cells with recommended growth media (see the specific lot information on the Certificate of Analysis for culture recommended dilution ratio) and dispense into a 25 cm2 or a 75 cm2 culture flask as recommended on the Certificate of Analysis) at a seeding density of 8.0 x 104 to 1.5 x 105 viable cells/cm2.
- Transfer the cell pellet to an appropriate size vessel. It is important to avoid excessive alkalinity of the medium during recovery of the cells. It is suggested that, prior to the addition of the vial contents, the culture vessel containing the growth medium be placed into the incubator for at least 15 minutes to allow the medium to reach its normal pH (7.0 to 7.6).
- Incubate the culture at 37°C in a suitable incubator. A 5% CO2 in air atmosphere is recommended if using the medium described on this product sheet.
Note: MCF7 (HTB-22) is typically a slow-growing cell line (will seem like it is not growing) and will appear as loosely attached three-dimensional clusters with some floating viable cells. It can take the HTB-22 cells 6-12 days to get to 80% confluence.
It is not unusual for MCF7 cells to display delayed attachment until after the first or second subculture.
- Subculturing procedure
-
Volumes used in this protocol are for 75 cm2 flasks; proportionally reduce or increase amount of dissociation medium for culture vessels of other sizes. Corning® T-75 flasks (catalog #430641) are recommended for subculturing this product.
Note: if floating cells are present, it is recommended that they be transferred at the first two (2) subcultures as described below. It is not necessary to transfer floating cells for subsequent subcultures.
- Remove culture medium to a centrifuge tube.
- Briefly rinse the cell layer with D-PBS (ATCC 30-2200) to remove all traces of serum which contains trypsin inhibitor.
- Add 2.0 to 3.0 mL of Trypsin-EDTA solution (ATCC 30-2101) to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).
Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal. - Add 6.0 to 8.0 mL of complete growth medium and aspirate cells by gently pipetting.
- Transfer the cell suspension to the centrifuge tube with the medium and cells from step 1, and centrifuge at approximately 125 xg for 5 to 10 minutes. Discard the supernatant.
- Resuspend the cell pellet in fresh growth medium. Add appropriate aliquots of the cell suspension to new culture vessels.
- Incubate cultures at 37°C.
Note:
The appearance of floating clusters during the first two subcultures is normal. These clusters should be gently broken up using smallbore pipette (5 mL or smaller). The cells should, after a few days’ incubation, reattach as three-dimensional islands (there still be some clusters that do not reattach). Growth will eventually spread out from the islands and the culture should, after the 2nd subculture. flatten and become 70-80% confluent.
Due to the semi-attached nature of this cell the minimum volume per vessel should be used to seed flasks. Until growth spreads out from the islands and the culture flattens. Treat as a semi-attached cell line by adding media as the clusters increase.
Subcultivation Ratio or Subculturing Seeding Density: A subcultivation ratio of 1:3 to 1:6 is recommended or a subculturing seeding density from 4.0 x 104 to 1.0 x 105 viable cells/cm2 is recommendedMedium Renewal: 2 to 3 times per week - Reagents for cryopreservation
- Complete growth medium supplemented with 5% (v/v) DMSO (ATCC 4-X)
Quality control specifications
- Bacterial and fungal testing
- Not detected
- Mycoplasma contamination
- Not detected
- Population doubling time
- Approximately 29 hrs
- STR profiling
- D3S1358: 16 TH01: 6 D21S11: 30 D18S51: 14 Penta_E: 7,12 D5S818: 11,12 D13S317: 11 D7S820: 8,9 D16S539: 11,12 CSF1PO: 10 Penta_D: 12 Amelogenin: X vWA: 14,15 D8S1179: 10,14 TPOX: 9,12 FGA: 23,25 D19S433: 13,14 D2S1338: 21,23
History
- Deposited as
- Homo sapiens
- Depositors
- CM McGrath
- Special collection
-
Human Tumor Cell Bank
- Cross references
-
GenBank U26553 Human calcitonin receptor mRNA, complete cds.GenBank U26554 Human calcitonin receptor isoform mRNA, complete cds.GenBank U63917 Human G protein coupled receptor (GPCR-Br) mRNA, complete cds.
Legal disclaimers
- Intended use
- This product is intended for laboratory research use only. It is not intended for any animal or human therapeutic use, any human or animal consumption, or any diagnostic use.
- Warranty
-
The product is provided 'AS IS' and the viability of ATCC® products is warranted for 30 days from the date of shipment, provided that the customer has stored and handled the product according to the information included on the product information sheet, website, and Certificate of Analysis. For living cultures, ATCC lists the media formulation and reagents that have been found to be effective for the product. While other unspecified media and reagents may also produce satisfactory results, a change in the ATCC and/or depositor-recommended protocols may affect the recovery, growth, and/or function of the product. If an alternative medium formulation or reagent is used, the ATCC warranty for viability is no longer valid. Except as expressly set forth herein, no other warranties of any kind are provided, express or implied, including, but not limited to, any implied warranties of merchantability, fitness for a particular purpose, manufacture according to cGMP standards, typicality, safety, accuracy, and/or noninfringement.
- Disclaimers
-
This product is intended for laboratory research use only. It is not intended for any animal or human therapeutic use, any human or animal consumption, or any diagnostic use. Any proposed commercial use is prohibited without a license from ATCC.
While ATCC uses reasonable efforts to include accurate and up-to-date information on this product sheet, ATCC makes no warranties or representations as to its accuracy. Citations from scientific literature and patents are provided for informational purposes only. ATCC does not warrant that such information has been confirmed to be accurate or complete and the customer bears the sole responsibility of confirming the accuracy and completeness of any such information.
This product is sent on the condition that the customer is responsible for and assumes all risk and responsibility in connection with the receipt, handling, storage, disposal, and use of the ATCC product including without limitation taking all appropriate safety and handling precautions to minimize health or environmental risk. As a condition of receiving the material, the customer agrees that any activity undertaken with the ATCC product and any progeny or modifications will be conducted in compliance with all applicable laws, regulations, and guidelines. This product is provided 'AS IS' with no representations or warranties whatsoever except as expressly set forth herein and in no event shall ATCC, its parents, subsidiaries, directors, officers, agents, employees, assigns, successors, and affiliates be liable for indirect, special, incidental, or consequential damages of any kind in connection with or arising out of the customer's use of the product. While reasonable effort is made to ensure authenticity and reliability of materials on deposit, ATCC is not liable for damages arising from the misidentification or misrepresentation of such materials.
Please see the material transfer agreement (MTA) for further details regarding the use of this product. The MTA is available at www.atcc.org.
Images
Frequently Asked Questions
References
Curated Citations
Sugarman BJ, et al. Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science 230: 943-945, 1985. PubMed: 3933111
Takahashi K, Suzuki K. Association of insulin-like growth-factor-I-induced DNA synthesis with phosphorylation and nuclear exclusion of p53 in human breast cancer MCF-7 cells. Int. J. Cancer 55: 453-458, 1993. PubMed: 8375929
Brandes LJ, Hermonat MW. Receptor status and subsequent sensitivity of subclones of MCF-7 human breast cancer cells surviving exposure to diethylstilbestrol. Cancer Res. 43: 2831-2835, 1983. PubMed: 6850594
Lan MS, et al. Polypeptide core of a human pancreatic tumor mucin antigen. Cancer Res. 50: 2997-3001, 1990. PubMed: 2334903
Pratt SE, Pollak MN. Estrogen and antiestrogen modulation of MCF7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor-binding proteins in conditioned media. Cancer Res. 53: 5193-5198, 1993. PubMed: 7693333
For product-related inquiries and issues, contact Product Experience:
Hours of Operation
US Eastern Time